Apithecary Pharma Private Limited

Apithecary Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2005PTC047834 Incorporated 20 October 2005 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.67 Lakh
▲ 17% YoY
Net profit · FY 2025
₹1.06 Lakh
Net margin 63.3%
EBITDA · FY 2025
₹1.06 Lakh
EBITDA margin 63.3%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.26 Cr
Issued & subscribed
Satisfied charges
₹14.53 Cr
No open charges
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings

About Apithecary Pharma Private Limited

Data last updated:

Apithecary Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 October 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PTC047834. The company has 3 GST registrations on record, none of which is active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.26 Cr. It is led by directors Munnamgi Radhika Reddy (Managing Director) and Munnamgi Anoushka Reddy.

Its last annual general meeting (AGM) was held on 29 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla Village, Hyderabad, Telangana, India – 500067.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.67 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹1.06 Lakh (net margin 63.3%) and EBITDA of ₹1.06 Lakh (EBITDA margin 63.3%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.

As per MCA filings, the company has satisfied charges of ₹14.53 Cr on record. Court records list 14 cases involving the company, including 10 filed by the company and 4 filed against it. The company has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹4.99 Cr; the latest was in March 2017.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apithecary.com.

Company details

CIN U24239TG2005PTC047834
Registration Number 047834
Incorporation Date 20 October 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Apithecary Pharma has one previous CIN (Corporate Identification Number): U24239AP2005PTC047834. The current CIN is U24239TG2005PTC047834, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2005PTC047834Current
U24239AP2005PTC047834Previous

Contact details

Apithecary Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is apithecary.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    H.No. 2 – 159/15 Prapurna Enclave Suchitra Circle Jeedimetla Village, Hyderabad, Telangana, India – 500067
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Apithecary Pharma Private Limited, buy the company report.

Comprehensive company report
Apithecary Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Apithecary Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Financials of Apithecary Pharma Private Limited

FY 2025 filings available

Apithecary Pharma Private Limited reported revenue of ₹1.67 Lakh (up 17% YoY) for FY 2025.

Revenue · FY 2025
₹1.67 Lakh ▲ 17%
Net profit · FY 2025
₹1.06 Lakh margin 63.3%
EBITDA · FY 2025
₹1.06 Lakh margin 63.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 10%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 109%
3 years · compounded
▲ 28%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 17% growth in the latest year. EBITDA rose 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.06 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.06 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin63.3%
Net Profit Margin63.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Apithecary Pharma Private Limited, buy the company report.

Board of directors of Apithecary Pharma Private Limited

Apithecary Pharma has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Munnamgi Radhika ReddyManaging Director20 Oct 200521 Years 0 MonthsCurrent
Munnamgi Anoushka ReddyDirector15 Mar 20215 Years 7 MonthsCurrent

Auditor

Apithecary Pharma Private Limited is audited by M.V.NARAYANAREDDY&CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M.V.NARAYANAREDDY&COFY 2023002370S

Shareholding

The shareholding of Apithecary Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Apithecary Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹14.53 Cr
Breakdown by lending institutions
Andhra Pradesh State Financial Corporation₹5.18 Cr
State Bank of India₹4.54 Cr
Andhra Pradesh State Finacial Corporation₹2.16 Cr
A P State Financial Corporation₹1.90 Cr
Andhra Bank₹0.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Jul 201310439158Andhra Pradesh State Financial Corporation₹2.18 CrSatisfied
20 Apr 201310420755Andhra Pradesh State Financial Corporation₹3 CrSatisfied
06 Oct 200910178109Andhra Pradesh State Finacial Corporation₹2.16 CrSatisfied
30 Jan 200910148487State Bank of India₹3.78 LakhSatisfied
13 Nov 200810133029State Bank of India₹4.5 CrSatisfied

To see the full charge records of Apithecary Pharma Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Apithecary Pharma Private Limited has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹4.99 Cr; the latest was in March 2017.

Total deals
10
Secondary share transfers
6
Funding rounds
4
Disclosed funding
₹4.99 Cr

Deals on record (5 of 10)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedBuyer: an individual
Seller: Sarala Project Works Private Limited
Dec 2016Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals
Feb 2015Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals
Mar 2013Funding round₹1.1 CrInvestors: Sarala Project Works Private Limited , an individual
Jun 2011Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

To see the full deal history of Apithecary Pharma Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Apithecary Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Apithecary Pharma has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
3
Cancelled / inactive
3

To see the full GST registrations and return filing status of Apithecary Pharma Private Limited, buy the company report.

Recent activity

Apithecary Pharma Private Limited has 10 board changes on record since 2005: 2 appointments and 8 cessations. The latest: Munnamgi Anoushka Reddy ceased to be Additional Director on 30 Sep 2021.

AGM
Apithecary Pharma Private Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records.
Filing
Apithecary Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Munnamgi Anoushka Reddy ceased to be Additional Director.
Appointed
Munnamgi Anoushka Reddy was appointed as Director.
Ceased
Narender Reddy Nalla ceased to be Director.
Charges
A charge registered on 30 Jan 2009 via Charge ID 10148487 with State Bank Of India was fully satisfied on 10 Sep 2014.
Charges
A charge registered on 13 Nov 2008 via Charge ID 10133029 with State Bank Of India was fully satisfied on 10 Sep 2014.
Charges
A charge registered on 20 Jul 2013 via Charge ID 10439158 with Andhra Pradesh State Financial Corporation was fully satisfied on 08 Sep 2014.
Charges
A charge registered on 20 Apr 2013 via Charge ID 10420755 with Andhra Pradesh State Financial Corporation was fully satisfied on 08 Sep 2014.
Charges
A charge registered on 06 Oct 2009 via Charge ID 10178109 with Andhra Pradesh State Finacial Corporation was fully satisfied on 08 Sep 2014.
Charges
A charge registered on 08 Jun 2006 via Charge ID 10005109 with A P State Financial Corporation was fully satisfied on 08 Sep 2014.
Charges
A charge with State Bank Of India of Rs. 4.50 Cr registered on 13 Nov 2008 with Charge ID 10133029 was modified on 31 Oct 2013.

18 earlier events are in the company report.

Frequently asked questions

Apithecary Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 October 2005 (21+ years old) and is registered under CIN U24239TG2005PTC047834.

Apithecary Pharma has 2 current directors:

The latest financial statements of Apithecary Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 August 2025. Year-wise statements from 2015 are in the company report.

No. Apithecary Pharma has 3 GST registrations on record and all of them are cancelled or inactive.

The CIN (Corporate Identification Number) of Apithecary Pharma is U24239TG2005PTC047834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Apithecary Pharma has 14 court cases on record: 10 filed by the company and 4 filed against it. Most are in the district courts.

Apithecary Pharma was incorporated on 20 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.

Apithecary Pharma has 10 deals on record (6 secondary share transfers, 4 funding rounds), with disclosed funding of ₹4.99 Cr; the latest was in March 2017.

Munnamgi Anoushka Reddy ceased to be Additional Director on 30 Sep 2021. Munnamgi Anoushka Reddy was appointed as Director on 15 Mar 2021. Narender Reddy Nalla ceased to be Director on 15 Mar 2021. Apithecary Pharma has 10 board changes on record in total.

Apithecary Pharma can be reached through the website apithecary.com. Its registered office is in Hyderabad, Telangana, India.